Verzenio is used to treat certain types of breast cancer. The drug can interact with several other medications, including antifungals, antiepileptics, and some heart medications. Although Verzenio isn ...

When taking Verzenio alone for breast cancer, the dosage is 200 mg twice per day. When taking Verzenio with other medications, such as fulvestrant, aromatase inhibitors, or tamoxifen, the dosage is ...

Novartis’ Kisqali is getting a leg up in the CDK4/6 breast cancer realm as another rival failed to significantly extend patients’ lives in a pivotal trial. A phase 3 study testing Eli Lilly’s Verzenio ...

Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter.

It may be more beneficial to reduce the dose of Verzenio rather than stop the drug altogether, according to the monarchE trial findings. Older patients with breast cancer still experienced a clinical ...